Humanigen Inc (NASDAQ: HGEN)
Some price data may be temporarily unavailable.
Humanigen Inc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Humanigen Inc Company Info
None
News & Analysis
What to Do When a Biotech Stock Skyrockets
Fear of missing out can lead investors in this space to hit the buy button at the worst possible times.
Why Humanigen Stock Is Sinking Today
The Food and Drug Administration turned down Emergency Use Authorization of lenzilumab in treating hospitalized COVID-19 patients.
Here's Why Humanigen Is Getting Hammered Today
An attempt to earn authorization for lenzilumab hit a wall at the FDA.
Why This COVID-19 Stock Is On Fire Right Now
While vaccines and diagnostics have been the big winners in the space so far, Humanigen might make investors a lot of money with its drug to treat cytokine storms caused by COVID-19.
2 Top Biotech Stocks to Buy Right Now
One is growing revenue. And the other may soon launch its first product.
Why Humanigen Stock Vaulted Higher Today
Detailed results from a late-stage study of the company's lead candidate were published online.
2 Juicy Biotech Stocks to Consider Buying Right Now
They're both innovating in attractive areas where there's no competition on the radar.
Reddit Traders Can't Get Enough of These 2 Resurgent Biotech Stocks
New coronavirus projects make them easy to hype, but they could face strong headwinds soon.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.